BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 25666327)

  • 1. Progressive multifocal leukoencephalopathy (PML) in a patient with lymphoma treated with rituximab: A case report and literature review.
    Al-Tawfiq JA; Banda RW; Daabil RA; Dawamneh MF
    J Infect Public Health; 2015; 8(5):493-7. PubMed ID: 25666327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive Multifocal Leukoencephalopathy Following Treatment with Rituximab in an HIV-Negative Patient with Non-Hodgkin Lymphoma. A Case Report and Literature Review.
    Felli V; Di Sibio A; Anselmi M; Gennarelli A; Sucapane P; Splendiani A; Catalucci A; Marini C; Gallucci M
    Neuroradiol J; 2014 Dec; 27(6):657-64. PubMed ID: 25489887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An autopsy case of progressive multifocal leukoencephalopathy after rituximab therapy for malignant lymphoma.
    Muto R; Sugita Y; Momosaki S; Ito Y; Wakugawa Y; Ohshima K
    Neuropathology; 2019 Feb; 39(1):58-63. PubMed ID: 30511425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive multifocal leukoencephalopathy in a patient with B-cell lymphoma during rituximab-containing chemotherapy: case report and review of the literature.
    Yokoyama H; Watanabe T; Maruyama D; Kim SW; Kobayashi Y; Tobinai K
    Int J Hematol; 2008 Nov; 88(4):443-447. PubMed ID: 18855101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab-associated progressive multifocal leukoencephalopathy.
    Sokol J; Lisá L; Zeleňáková J; Balhárek T; Plameňová I; Staško J; Kubisz P
    Vnitr Lek; 2017; 63(1):60-64. PubMed ID: 28225293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive multifocal leukoencephalopathy masquerading as cerebellar infarction.
    Willott RH; Sunman W; Munshi SK
    Age Ageing; 2016 Jul; 45(4):564-5. PubMed ID: 27056083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progressive multifocal leukoencephalopathy after rituximab therapy in a patient with mantle cell lymphoma].
    Ota I; Katsura Y; Yoshida C; Yoshizawa K; Ohtani H; Sata T; Komeno T
    Rinsho Ketsueki; 2010 Dec; 51(12):1786-8. PubMed ID: 21258190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depletion of B lymphocytes from cerebral perivascular spaces by rituximab.
    Martin Mdel P; Cravens PD; Winger R; Kieseier BC; Cepok S; Eagar TN; Zamvil SS; Weber MS; Frohman EM; Kleinschmidt-Demasters BK; Montine TJ; Hemmer B; Marra CM; Stüve O
    Arch Neurol; 2009 Aug; 66(8):1016-20. PubMed ID: 19667224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab-associated progressive multifocal leukoencephalopathy derived from non-Hodgkin lymphoma: neuropathological findings and results of mefloquine treatment.
    Sano Y; Nakano Y; Omoto M; Takao M; Ikeda E; Oga A; Nakamichi K; Saijo M; Maoka T; Sano H; Kawai M; Kanda T
    Intern Med; 2015; 54(8):965-70. PubMed ID: 25876582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive multifocal leukoencephalopathy during treatment with rituximab and CHOP chemotherapy in a patient with a diffuse large B-cell lymphoma.
    Sikkema T; Schuiling WJ; Hoogendoorn M
    BMJ Case Rep; 2013 Jan; 2013():. PubMed ID: 23355583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal progressive multifocal leukoencephalopathy in a patient with non-Hodgkin lymphoma treated with rituximab.
    Paues J; Vrethem M
    J Clin Virol; 2010 Aug; 48(4):291-3. PubMed ID: 20558102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of progressive multifocal leukoencephalopathy presenting white matter MRI lesions extending over the cerebral cortex and a marked decrease in cerebral blood flow on SPECT, and associated with HTLV-I infection].
    Takase K; Ohyagi Y; Furuya H; Nagashima K; Taniwaki T; Kira J
    Rinsho Shinkeigaku; 2005 Jun; 45(6):426-30. PubMed ID: 16022467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive multifocal leukoencephalopathy in patients treated with rituximab: a 20-year review from the Southern Network on Adverse Reactions.
    Bennett CL; Focosi D; Socal MP; Bian JC; Nabhan C; Hrushesky WJ; Bennett AC; Schoen MW; Berger JR; Armitage JO;
    Lancet Haematol; 2021 Aug; 8(8):e593-e604. PubMed ID: 34329579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive multifocal leukoencephalopathy following rituximab treatment in a patient with rheumatoid arthritis.
    Fleischmann RM
    Arthritis Rheum; 2009 Nov; 60(11):3225-8. PubMed ID: 19877057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive multifocal leukoencephalopathy in a lymphoma patient with complete remission after treatment with cytostatics and rituximab: case report and review of the literature.
    Freim Wahl SG; Folvik MR; Torp SH
    Clin Neuropathol; 2007; 26(2):68-73. PubMed ID: 17416105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive Multifocal Leukoencephalopathy Following Combined Rituximab-Based Immune-Chemotherapy for Post-transplant Lymphoproliferative Disorder in a Renal Transplant Recipient: A Case Report.
    Windpessl M; Burgstaller S; Kronbichler A; Pieringer H; Kalev O; Karrer A; Wallner M; Thaler J
    Transplant Proc; 2018 Apr; 50(3):881-883. PubMed ID: 29661457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive multifocal encephalopathy after cyclophosphamide in granulomatosis with polyangiitis (Wegener) patients: case report and review of literature.
    Pugnet G; Pagnoux C; Bézanahary H; Ly KH; Vidal E; Guillevin L
    Clin Exp Rheumatol; 2013; 31(1 Suppl 75):S62-4. PubMed ID: 23663683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Atypical progressive multifocal leukoencephalopathy (PML) in a patient with pulmonary sarcoidosis].
    Le Guilloux J; Roubiou C; Mallet J; Bouvry D; Alkhalil A; Coman I; Belin C; Gorochov G; Carpentier A; Mokhtari K; Carpentier AF
    Rev Neurol (Paris); 2010 Mar; 166(3):341-5. PubMed ID: 19589551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An autopsy case of progressive multifocal leukoencephalopathy with massive iron deposition in juxtacortical lesions.
    Okamoto K; Takeda A; Hatsuta H; Sano T; Takao M; Ohsawa M; Miki Y; Nakamichi K; Itoh Y
    Neuropathology; 2023 Oct; 43(5):396-402. PubMed ID: 36847459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis.
    Clifford DB; Ances B; Costello C; Rosen-Schmidt S; Andersson M; Parks D; Perry A; Yerra R; Schmidt R; Alvarez E; Tyler KL
    Arch Neurol; 2011 Sep; 68(9):1156-64. PubMed ID: 21555606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.